InvestorsHub Logo
Followers 1
Posts 158
Boards Moderated 0
Alias Born 05/06/2019

Re: None

Friday, 12/03/2021 1:42:37 PM

Friday, December 03, 2021 1:42:37 PM

Post# of 3535
Abbott sues DexCom over glucose-monitoring patent settlement, license

https://www.reuters.com/legal/transactional/abbott-sues-dexcom-over-glucose-monitoring-patent-settlement-license-2021-12-02/

An Abbott Laboratories subsidiary focused on diabetes care sued rival DexCom in Delaware federal court for allegedly violating a 2014 settlement agreement and asked the court to declare that Abbott doesn't infringe its patents.

The lawsuit filed Wednesday is sealed, and the motion to seal says it relates to Abbott's Freestyle Libre continuous glucose monitoring system.

Chicago-based Abbott made more than $2.6 billion from worldwide sales of Freestyle Libre products last year, according to a filing with the U.S. Securities and Exchange Commission. DexCom's flagship G6 system is a rival to the Freestyle Libre.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KNW News